Modeling the developmental origins of pediatric cancer to improve patient outcomes

Area of Science:

• Pediatric Oncology
• Cancer Genomics
• Translational Cancer Research

Background:

• Multimodal cancer therapies (surgery, chemotherapy, radiation) improve survival but cause lifelong health problems in survivors.
• Current pediatric cancer treatments inadequately incorporate advances in understanding molecular mechanisms.
• Next-generation sequencing has identified numerous genetic aberrations in tumors, but their functional impact remains unclear.

Purpose of the Study:

• To discuss key challenges in pediatric cancer research and treatment from a physician-scientist's viewpoint.
• To highlight promising new approaches for transforming the understanding and treatment of pediatric cancers.
• To emphasize the need for multidisciplinary collaboration and improved preclinical models.

Main Methods:

• Review of current challenges in pediatric oncology.
• Discussion of advances in next-generation sequencing and cancer genomics.
• Exploration of the role of preclinical models in understanding tumor development.

Main Results:

• Most pediatric cancer patients can be cured with multimodal therapy, but survivors face significant long-term health issues.
• Genetic aberrations cataloged by next-generation sequencing offer potential therapeutic targets.
• Understanding how genetic changes drive cancer requires better preclinical models reflecting the in vivo environment.

Conclusions:

• Transforming pediatric cancer care necessitates a deeper understanding of molecular mechanisms and improved therapeutic strategies.
• Multidisciplinary collaboration and the development of representative preclinical models are crucial for advancing research.
• New approaches hold promise for improving outcomes for children and adolescents with cancer.